These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21883990)

  • 1. Clopidogrel resistance: identifying and overcoming a barrier to effective antiplatelet treatment.
    Uchiyama S
    Cardiovasc Ther; 2011 Dec; 29(6):e100-11. PubMed ID: 21883990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the monitoring of anti-P2Y12 therapy.
    Harrison P
    Platelets; 2012; 23(7):510-25. PubMed ID: 22916724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amlodipine on platelet inhibition by clopidogrel in patients with ischaemic heart disease: a randomised, controlled trial.
    Li AY; Ng FH; Chan FK; Tunggal P; Chan K; Lau YK
    Heart; 2013 Apr; 99(7):468-73. PubMed ID: 23118347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel.
    Ma TK; Lam YY; Tan VP; Kiernan TJ; Yan BP
    Pharmacol Ther; 2010 Feb; 125(2):249-59. PubMed ID: 19919843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.
    Suh JW; Koo BK; Zhang SY; Park KW; Cho JY; Jang IJ; Lee DS; Sohn DW; Lee MM; Kim HS
    CMAJ; 2006 Jun; 174(12):1715-22. PubMed ID: 16754899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel resistance?
    Gurbel PA; Tantry US
    Thromb Res; 2007; 120(3):311-21. PubMed ID: 17109936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.
    Siller-Matula J; Schrör K; Wojta J; Huber K
    Thromb Haemost; 2007 Mar; 97(3):385-93. PubMed ID: 17334505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interaction between clopidogrel and proton pump inhibitors.
    Khalique SC; Cheng-Lai A
    Cardiol Rev; 2009; 17(4):198-200. PubMed ID: 19525682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):532-9. PubMed ID: 20729752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness to P2Y12 receptor inhibitors.
    Esposito G
    Curr Opin Cardiol; 2011 Dec; 26 Suppl 1():S31-7. PubMed ID: 22129581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of clopidogrel and statins: a hypothetical interaction or therapeutic dilemma?
    Tafreshi MJ; Zagnoni LG; Gentry EJ
    Pharmacotherapy; 2006 Mar; 26(3):388-94. PubMed ID: 16503718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
    Tran M; Tafreshi J; Pai RG
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel-drug interactions.
    Bates ER; Lau WC; Angiolillo DJ
    J Am Coll Cardiol; 2011 Mar; 57(11):1251-63. PubMed ID: 21392639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S; Roe MT
    Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?
    Kowalczyk M; Banach M; Mikhailidis DP; Hannam S; Rysz J
    Med Sci Monit; 2009 Dec; 15(12):MS24-30. PubMed ID: 19946242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.
    Bernlochner I; Byrne RA; Kastrati A; Sibbing D
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):999-1014. PubMed ID: 21878045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticagrelor: a novel reversible oral antiplatelet agent.
    Nawarskas JJ; Clark SM
    Cardiol Rev; 2011; 19(2):95-100. PubMed ID: 21285670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prasugrel resistance: fact or fiction.
    Alexopoulos D
    Platelets; 2012; 23(2):83-90. PubMed ID: 21787175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel resistance.
    Oqueli E; Hiscock M; Dick R
    Heart Lung Circ; 2007; 16 Suppl 3():S17-28. PubMed ID: 17611155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.